medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2018, Número 5

<< Anterior Siguiente >>

Ann Hepatol 2018; 17 (5)


Chronic Hepatitis C Patients with Obesity: Do We Need Two Operators for Accurate Evaluation of Liver Stiffness?

Shiha GE, El-Etreby S, Bahgat M, Hamed M, El Sherbini M, Ghoneem EA, Zalata K, Soliman RE, ElBasiouny MA, Mikhail NNH

Idioma: Ingles.
Referencias bibliográficas: 35
Paginas: 795-801
Archivo PDF: 157.88 Kb.


RESUMEN

Sin resumen.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Bravo AA, Sheth SG, Chopra S. Liver biopsy. N Engl J Med 2001; 344: 495-500.

  2. Saadeh S, Cammell G, Carey WD, Younossi Z, Barnes D, Easley K. The role of liver biopsy in chronic hepatitis C. Hepatology 2001; 33: 196-200.

  3. Piccinino F, Sagnelli E, Pasquale G, Giusti G. Complications following percutaneous liver biopsy. A multicentre retrospective study on 68,276 biopsies. J Hepatol 1986; 2: 165-73.

  4. Bedossa P, Dargere D, Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 2003; 38: 1449-57.

  5. Guido M, Rugge M. Liver biopsy sampling in chronic viral hepatitis. Semin Liver Dis 2004; 24: 89-97.

  6. Colloredo G, Guido M, Sonzogni A, Leandro G. Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: the smaller the sample, the milder the disease. J Hepatol 2003; 39: 239-44.

  7. Rousselet MC, Michalak S, Dupre F, Croué A, Bedossa P, Saint-André JP, Calès P. Hepatitis Network 49. Sources of variability in histological scoring of chronic viral hepatitis. Hepatology 2005; 41: 257-64.

  8. Ziol M, Handra-Luca A, Kettaneh A, Christidis C, Mal F, Kazemi F, de Lédinghen V, et al. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology 2005; 41: 48-54.

  9. Castera L, Vergniol J, Foucher J, Le Bail B, Chanteloup E, Haaser M, Darriet M, et al. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 2005; 128: 343-50.

  10. Ganne-Carrie N, Ziol M, de Le’dinghen V, Douvin C, Marcellin P, Castera L, Dhumeaux D, et al. Accuracy of liver stiffness measurement for the diagnosis of cirrhosis in patients with chronic liver diseases. Hepatology 2006; 44: 1511-17.

  11. Fraquelli M, Rigamonti C, Casazza G, Conte D, Donato MF, Ronchi G, Colombo M. Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver disease. Gut 2007; 56: 968-73.

  12. Foucher J, Chanteloup E, Vergniol J, Castera L, Le Bail B, Adhoute X, Bertet J, et al. Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study. Gut 2006; 55: 403-8.

  13. World Health Organization. Obesity and overweight: Fact Sheet. http://www.who.int/mediacentre/factsheets/fs311/ en/Accessed 4 October 2017.

  14. Carrión JA, Puigvehí M, Coll S, Garcia-Retortillo M, Cañete N, Fernández R, Márquez C, et al. Applicability and accuracy improvement of transient elastography using the M and XL probes by experienced operators. J Viral Hepat 2015; 22: 297-306.

  15. Castera L, Foucher J, Bernard PH, Carvalho F, Allaix D, Merrouche W, Couzigou P, et al. Pitfalls of liver stiffness measurement: a 5-year prospective study of 13,369 examinations. Hepatology 2010; 51: 828-35.

  16. Ferraioli G, Filice C, Castera L, Choi BI, Sporea I, Wilson SR, Cosgrove D, et al. WFUMB guidelines and recommendations for clinical use of ultrasound elastography: Part 3: liver. Ultrasound Med Biol 2015; 41: 1161-79.

  17. Puigvehí M, Broquetas T, Coll S, Garcia-Retortillo M, Cañete N, Fernández R, Gimeno J, et al. Impact of anthropometric features on the applicability and accuracy of FibroScan® (M and XL) in overweight/obese patients. J Gastroenterol Hepatol 2017; 32: 1746-53.

  18. Deuffic-Burban S, Mohamed SK, Larouze B, Carrat F, Valleron AJ. Expected increase in hepatitis C related mortality in Egypt due to pre-2000 infections. J Hepatol 2006; 44: 455-61.

  19. Breban R, Doss W, Esmat G, Elsayed M, Hellard M, Ayscue P, Albert M, et al. Towards realistic estimates of HCV incidence in Egypt. J Viral Hepat 2013; 20: 294-6.

  20. Ministry of Health and Population, Egypt. Plan of Action for the Prevention, Care and Treatment of Viral Hepatitis, Egypt 2014-2018.

  21. Gaia S, Carenzi S, Barilli AL Bugianesi E, Smedile A, Brunello F, Marzano A, et al. Reliability of transient elastography for the detection of fibrosis in nonalcoholic fatty liver disease and chronic viral hepatitis. J Hepatol 2011; 54: 64-71.

  22. Tsochatzis EA, Gurusamy KS, Ntaoula S, Cholongitas E, Davidson BR, Burroughs AK. Elastography for the diagnosis of severity of fibrosis in chronic liver disease: a meta-analysis of diagnostic accuracy. J Hepatol 2011; 54: 650-9.

  23. Poynard T, Ingiliz P, Elkrief L, Munteanu M, Lebray P, Morra R, Messous D, et al. Concordance in a world without a gold standard: a new non-invasive methodology for improving accuracy of fibrosis markers. PLoS ONE 2008; 3: e3857.

  24. Bedossa P. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. The French METAVIR Cooperative Study Group. Hepatology 1994; 20: 15-20.

  25. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; 1: 307-10.

  26. Shiha G, El-Etreby S, Bahgat M, Hamed M, El Sherbini M, Ghoneem EA, Zalata K, et al. Comparison between Transient Elastography (FibroScan) and Liver Biopsy for the Diagnosis of Hepatic Fibrosis in Chronic Hepatitis C Patients. MJVH 2016; 2: 17-25. http://elriah.liver-ri.org.eg/mjvh/Issues/issue3/ 7- Article 3.pdf

  27. Boursier J, Konate A, Gorea G, Reaud S, Quemener E, Oberti F, Hubert-Fouchard I, et al. Reproducibility of liver stiffness measurement by ultrasonographic elastometry. Clin Gastroenterol Hepatol 2008; 6: 1263-9.

  28. Neukam K, Recio E, Camacho A, Macías J, Rivero A, Mira JA, López C, et al. Interobserver concordance in the assessment of liver fibrosis in HIV/HCV-coinfected patients using transient elastometry. Eur J Gastroenterol Hepatol 2010; 22: 801-7.

  29. Roca B, Resino E, Torres V, Herrero E, Penades M. Interobserver discrepancy in liver fibrosis using transient elastography. J Viral Hepat 2012; 19: 711-5.

  30. Perazzo H, Fernandes FF, Gomes A, Terra C, Perez RM, Figueiredo FA. Interobserver variability in transient elastography analysis of patients with chronic hepatitis C. Liver Int 2015; 35: 1533-9.

  31. Sebastiani G, Castera L, Halfon P, Pol S, Mangia A, Di Marco V, Pirisi M, et al. The impact of liver disease aetiology and the stages of hepatic fibrosis on the performance of non-invasive fibrosis biomarkers: an international study of 2411 cases. Aliment Pharmacol Ther 2011; 34: 1202-16.

  32. Poynard T, De Ledinghen V, Zarski JP, Stanciu C, Munteanu M, Vergniol J, France J, et al. FibroTest and Fibroscan performances revisited in patients with chronic hepatitis C. Impact of the spectrum effect and the applicability rate. Clin Res Hepatol Gastroenterol 2011; 35: 720-30.

  33. De Ledinghen V, Vergniol J. Transient elastography (FibroScan). Gastroenterol Clin Biol 2008; 32: 58-67.

  34. Wong GL, Wong VW, Chim AM, Yiu KK, Chu SH, Li MK, Chan HL. Factors associated with unreliable liver stiffness measurement and its failure with transient elastography in the Chinese population. J Gastroenterol Hepatol 2011; 26: 300-5.

  35. Chou R, Wasson N. Blood tests to diagnose fibrosis or cirrhosis in patients with chronic hepatitis C virus infection: a systematic review. Ann Intern Med 2013; 158: 807-20.




2020     |     www.medigraphic.com